Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Abstract This paper discusses the administrative aspects of molecular diagnostics in oncology, including US Food and Drug Administration (FDA) oversight, the regulatory approval process, clinical, and ...
Labroots is excited to announce our 15th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2027 held on May 12th, 2027! The Precision Medicine: Genomics, ...
Faster Test Results for Infection Lead to Safer and More Cost-Effective Hospitals The process of culture-based testing for microbes has been in common use for more than a century. In recent decades, ...
ROCKVILLE, Md. – May 27, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the release of a three-part series of scientific ...
The Southern blot, which detects specific DNA sequences, was one of the first molecular diagnostic methods to be widely adopted. 2 This type of probe-based assay uses a single-stranded oligonucleotide ...
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026 held on May 13th, 2026! The Precision Medicine: Genomics, ...
Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models The following represents disclosure information provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results